By understanding how milligram to kilogram peptide production is achieved safely, drug developers can better navigate the ...
Nutriband Inc. has successfully completed the scale-up of the commercial manufacturing process for its lead product, Aversa™ Fentanyl, in partnership with Kindeva, a contract development and ...
Translating regenerative medicine from lab research to large-scale clinical and commercial production requires robust, scalable, and tightly controlled ...
Minaris expands commercial manufacturing for LYFGENIA™, a first-in-class FDA approved gene therapy for patients with sickle cell disease Expanded capacity meets growing patient demand while delivering ...
Challenges and Opportunities in Highly Potent Active Pharmaceutical Ingredient (HPAPI) Manufacturing
Highly potent active pharmaceutical ingredients (HPAPIs) are at the forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is ...
Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...
Manufacturing’s future is inextricably linked with robotic advancement. Organizations embracing these transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results